跳至主要内容
临床试验/JPRN-UMIN000000957
JPRN-UMIN000000957已完成4 期

Clinical study of Landiolol hydrochloride in the treatment of postoperative atrial fibrillation/atrial flutter after cardiovascular surgery - JL-Knight Study (Japan Landiolol-Kicking off the novel investigation for gold standard heart study)

JL-Knight Study Group0 个研究点目标入组 400 人开始时间: 2007年12月27日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)acute myocardial infarction within 3 days (2)supraventricular arrhythmia (3)sick sinus syndrome (containing patients with pacemaker) (4)grave heart failure (preoperative NYHA Classification of the Stages of Heart Failure, more than or equal to third degree) (5)atrioventricular block, more than or equal to second degree (6)contraindication to beta-blockers or , calcium channel blockers (7)electrolyte imbalance, WPW syndrome or hyperthyroidism (8)blood pressure < 90/60 mmHg (9)postoperative peroral use of beta-blockers or, calcium channel blockers (10)use of operative and postoperative antiarrhythmic medications excluding Digitalis

研究者

发起方
JL-Knight Study Group

相似试验